Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.5.1.42 extracted from

  • Di Stefano, M.; Loreto, A.; Orsomando, G.; Mori, V.; Zamporlini, F.; Hulse, R.P.; Webster, J.; Donaldson, L.F.; Gering, M.; Raffaelli, N.; Coleman, M.P.; Gilley, J.; Conforti, L.
    NMN deamidase delays Wallerian degeneration and rescues axonal defects caused by NMNAT2 deficiency in vivo (2017), Curr. Biol., 27, 784-794 .
    View publication on PubMed
Search for more literature for 3.5.1.42

Cloned(Commentary)

Cloned (Comment) Organism
recombinant expression of NMN deamidase fused to EGFP in transgenic mice and zebrafish larvae Escherichia coli

Protein Variants

Protein Variants Comment Organism
additional information NMN deamidase blocks Wallerian degeneration in transgenic zebrafish larvae. NMN deamidase also rescues axonal outgrowth and perinatal lethality in a dose-dependent manner in mice lacking NMNAT2. Recombinant NMN deamidase delays Wallerian degeneration and rescues axonal defects caused by NMNAT2 deficiency in vivo. NMN deamidase protection is neuron specific and effective against various toxic insults. NMN deamidase expression confers morphological and functional preservation of transected axons Escherichia coli

Natural Substrates/ Products (Substrates)

Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
nicotinamide mononucleotide + H2O Escherichia coli
-
 nicotinate mononucleotide + NH3
-
 ?

Organism

Organism UniProt Comment Textmining
Escherichia coli
-
-
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
additional information NMN deamidase lacks intrinsic NAD synthesis activity Escherichia coli ?
-
 ?
nicotinamide mononucleotide + H2O
-
 Escherichia coli nicotinate mononucleotide + NH3
-
 ?

Synonyms

Synonyms Comment Organism
NMN deamidase
-
 Escherichia coli

General Information

General Information Comment Organism
physiological function recombinant NMN deamidase delays Wallerian degeneration and rescues axonal defects caused by NMNAT2 deficiency in vivo. NMN-consuming activity with axonal NAD-synthesizing enzyme NMNAT2, but not NAD-synthesizing activity, and it delays axon degeneration in primary neuronal cultures. Transgenic NMN deamidase protection is neuron specific and effective against various toxic insults. NMN deamidase prevents NMN accumulation in injured sciatic nerves Escherichia coli